NOVARTIS AG (NVSEF)
Clinical trial NCT06462469 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-21 → 2027-07-08 3. primary completion date: 2026-09-24 → 2026-09-02 4. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT06462469 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-06-21 → 2027-07-08 3. primary completion date: 2026-09-24 → 2026-09-02 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical